Companies / Beam Therapeutics Inc. / Activity
Activity — Beam Therapeutics Inc.
30 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Ciaramella Giuseppe Executive | Sell | Common Stock | $1.12M | -35K -15.54% | 190,216 0.18% of shares | medium |
| Jan 30, 2026 | Evans John M. CEO | Sell | Common Stock | $624.7K | -22K -2.18% | 989,573 0.96% of shares | medium |
| Feb 24, 2026 | Ciaramella Giuseppe Executive | Exercise | Common Stock | $595.0K | +35K +18.40% | 225,216 0.22% of shares | low |
| Jan 15, 2026 | Bellon Christine Executive | Sell | Common Stock | $554.1K | -16K -14.05% | 97,597 0.09% of shares | medium |
| Jan 29, 2026 | Evans John M. CEO | Sell | Common Stock | $476.8K | -16K -1.61% | 995,334 0.96% of shares | medium |
| Jan 29, 2026 | Evans John M. CEO | Sell | Common Stock | $257.8K | -9K -0.87% | 986,667 0.96% of shares | medium |
| Jan 22, 2026 | Cavanagh Bethany J Executive | Sell | Common Stock | $216.9K | -6K -15.11% | 34,813 0.03% of shares | medium |
| Dec 31, 2025 | Emany Sravan Kumar Executive | Sell | Common Stock | $170.6K | -6K -7.87% | 73,706 0.07% of shares | medium |
| Jan 20, 2026 | Cavanagh Bethany J Executive | Sell | Common Stock | $91.4K | -3K -6.89% | 41,011 0.04% of shares | low |
| Jan 30, 2026 | Evans John M. CEO | Sell | Common Stock | $84.3K | -3K -0.29% | 986,667 0.96% of shares | low |
| Jan 15, 2026 | Bellon Christine Executive | Sell | Common Stock | $71.0K | -2K -1.83% | 113,556 0.11% of shares | low |
| Jan 22, 2026 | Bellon Christine Executive | Sell | Common Stock | $46.6K | -1K -1.41% | 95,667 0.09% of shares | low |
| Dec 31, 2025 | Bellon Christine Executive | Sell | Common Stock | $34.0K | -1K -1.07% | 115,667 0.11% of shares | low |
| Jan 15, 2026 | Bellon Christine Executive | Sell | Common Stock | $19.8K | -559 -0.57% | 97,038 0.09% of shares | low |
| Jan 30, 2026 | Evans John M. CEO | Exercise | Common Stock | $16.8K | +25K +2.53% | 1,011,667 0.98% of shares | low |
| Jan 29, 2026 | Evans John M. CEO | Exercise | Common Stock | $13.0K | +19K +1.96% | 1,006,003 0.97% of shares | low |
| Jan 29, 2026 | Evans John M. CEO | Exercise | Common Stock | $3.8K | +6K +0.56% | 1,011,667 0.98% of shares | low |
| Dec 31, 2025 | Simon Amy Executive | Grant | Common Stock | $0 | +13K +19.27% | 77,364 0.07% of shares | low |
| Jun 3, 2026 | Cooper Graham K Director | Grant | Stock Option (Right to Buy) | — | +20K | 19,676 0.02% of shares | low |
| Jun 3, 2026 | Maraganore John Director | Grant | Stock Option (Right to Buy) | — | +20K | 19,676 0.02% of shares | low |
| Feb 24, 2026 | Ciaramella Giuseppe Executive | Exercise | Stock Option (Right to Buy) | — | -35K -8.10% | 397,313 0.38% of shares | low |
| Jan 31, 2026 | Ciaramella Giuseppe Executive | Grant | Stock Option (Right to Buy) | — | +80K | 80,000 0.08% of shares | low |
| Jan 31, 2026 | Evans John M. CEO | Grant | Stock Option (Right to Buy) | — | +180K | 180,000 0.17% of shares | low |
| Jan 30, 2026 | Evans John M. CEO | Exercise | Stock Option (Right to Buy) | — | -25K -26.69% | 68,672 0.07% of shares | low |
| Jan 29, 2026 | Evans John M. CEO | Exercise | Stock Option (Right to Buy) | — | -6K -5.70% | 93,672 0.09% of shares | low |
| Jan 29, 2026 | Evans John M. CEO | Exercise | Stock Option (Right to Buy) | — | -19K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Cavanagh Bethany J Executive | Grant | Stock Option (Right to Buy) | — | +40K | 40,000 0.04% of shares | low |
| Jan 31, 2026 | Emany Sravan Kumar Executive | Grant | Stock Option (Right to Buy) | — | +64K | 63,500 0.06% of shares | low |
| Jan 31, 2026 | Bellon Christine Executive | Grant | Stock Option (Right to Buy) | — | +40K | 40,000 0.04% of shares | low |
| Jan 31, 2026 | Simon Amy Executive | Grant | Stock Option (Right to Buy) | — | +89K | 88,500 0.09% of shares | low |